Tortugas Neuroscience is a neurology-focused biotech company developing novel medicines.
Tortugas Neuroscience has raised $106.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Tortugas Neuroscience's investors include The Column Group, AN Ventures, Cure Ventures.
Tortugas Neuroscience is headquartered in Framingham, United States.
Tortugas Neuroscience is a neurology-focused biotech company developing novel medicines.
Tortugas Neuroscience is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tortugas Neuroscience — Funding & Investors." VCBacked, April 21, 2026, https://www.vcbacked.co/company/tortugas-neuroscience. Accessed October 23, 2026.
VCBacked. (2026). Tortugas Neuroscience — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/tortugas-neuroscience
{{cite web |title=Tortugas Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/tortugas-neuroscience |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated